- Home
- NECB vs ATYR Comparison
NECB vs ATYR Comparison
Compare NECB & ATYR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NECB
- ATYR
- Stock Information
- Founded
- NECB 1934
- ATYR 2005
- Country
- NECB United States
- ATYR United States
- Employees
- NECB N/A
- ATYR N/A
- Industry
- NECB Savings Institutions
- ATYR Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- NECB Finance
- ATYR Health Care
- Exchange
- NECB Nasdaq
- ATYR Nasdaq
- Market Cap
- NECB 294.0M
- ATYR 330.7M
- IPO Year
- NECB N/A
- ATYR 2015
- Fundamental
- Price
- NECB $23.14
- ATYR $4.32
- Analyst Decision
- NECB
- ATYR Strong Buy
- Analyst Count
- NECB 0
- ATYR 6
- Target Price
- NECB N/A
- ATYR $18.60
- AVG Volume (30 Days)
- NECB 49.2K
- ATYR 1.0M
- Earning Date
- NECB 01-29-2025
- ATYR 03-13-2025
- Dividend Yield
- NECB 2.81%
- ATYR N/A
- EPS Growth
- NECB 7.83
- ATYR N/A
- EPS
- NECB 3.58
- ATYR N/A
- Revenue
- NECB $105,835,000.00
- ATYR $235,000.00
- Revenue This Year
- NECB N/A
- ATYR N/A
- Revenue Next Year
- NECB $8.02
- ATYR $1,299.74
- P/E Ratio
- NECB $6.46
- ATYR N/A
- Revenue Growth
- NECB 6.02
- ATYR N/A
- 52 Week Low
- NECB $14.26
- ATYR $1.42
- 52 Week High
- NECB $31.72
- ATYR $4.66
- Technical
- Relative Strength Index (RSI)
- NECB 30.92
- ATYR 63.39
- Support Level
- NECB $23.42
- ATYR $3.38
- Resistance Level
- NECB $24.17
- ATYR $3.81
- Average True Range (ATR)
- NECB 0.67
- ATYR 0.27
- MACD
- NECB -0.12
- ATYR 0.06
- Stochastic Oscillator
- NECB 3.69
- ATYR 74.44
About NECB NorthEast Community Bancorp Inc.
NorthEast Community Bancorp Inc operates as a community-oriented financial institution. It is principally engaged in the business of attracting deposits and investing those funds into mortgage and commercial loans. They conduct their activities throughout the Northeastern United States including New York, Massachusetts, New Jersey, and Connecticut. The company offers a comprehensive line of banking products and services, including mobile banking as well as commercial real estate loans, commercial construction financing, lines of credit, and term loans. It also offers investment advisory and financial planning services.
About ATYR aTyr Pharma Inc. Common Stock
aTyr Pharma Inc is a biotherapeutics company engaged in the discovery and development of first-in-class medicines from its proprietary tRNA synthetase platform. The company has concentrated its research and development efforts on a newly discovered area of biology, the extracellular functionality and signaling pathways of tRNA synthetases. Its primary focus is efzofitimod, a clinical-stage product candidate which targets NRP2 to resolve chronic inflammation that can lead to fibrosis. Efzofitimod has a novel mechanism of action for potentially treating lung inflammation and fibrosis.